The shortlist

Alternatives to Goldspan Health

Goldspan Health sits at No. 80 in our ranking with a Brief Score of 76. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs Goldspan Health.

Our top alternative

No. 1 here

Brief Score

94/100

Editorial rating

CoreAge Rx

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Semaglutide: From $79/mo
Annual offer: 12 months paid upfront, from $948.
Main site: from $99/mo; confirm the selected offer.
Full price details
From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo
Tirzepatide: From $129/mo
Annual offer: 12 months paid upfront, from $1,548.
Main site: from $149/mo; confirm the selected offer.
Full price details
From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo
Coverage: US only; restrictions by state, confirmed at intake

Visit CoreAge Rx CoreAge Rx vs Goldspan Health →

More providers worth weighing

No. 8 · Grade B

MadeMed

86/100

MadeMed publishes quarterly and six-month prices for injectable and sublingual treatment; the full term is prepaid, and supply timing needs confirmation.

Semaglutide: $239/mo injectable
Quarterly prepay: $717 upfront; no monthly plan.
Sublingual: $219/mo, $657 upfront quarterly. Six-month options cost less.
Full price details
$239/mo injectable and $219/mo sublingual on the quarterly plan ($717 / $657 in one charge); $199 and $179 on the 6-month plan. No month-to-month option
Coverage: Availability varies by treatment and state; confirm the selected product before prepaying
Price trend: price stable

Visit Read the brief →

No. 31 · Grade B−

Direct Meds

82/100

A newer (2024) compounding provider whose real hook is form: it runs an oral/sublingual line alongside the usual injections, on both molecules, with no membership tacked on.

Semaglutide: $249/mo sublingual · $297/mo injectable — both billed monthly on a 3-month minimum commitment
Coverage: Not publicly listed
Price trend: price stable

Visit Read the brief →

FDA warning letter, September 2025 — issued to directmeds.com, Inc. dba DirectMeds. See the FDA's warning letter database.

No. 93 · Grade C

Fitish

75/100

Fitish lists an inclusive $339 monthly tirzepatide supply; refund wording and the next refill's terms deserve confirmation.

Semaglutide: Confirm current price
Earlier listing: $219/mo compounded semaglutide; current product quote could not be reconfirmed.
Full price details
Compounded semaglutide offered. Current medication quote unknown; earlier observed $219/mo compounded; current semaglutide product page was unavailable during review
Coverage: Confirm current prescription-specific state access; no complete coverage list verified
Price trend: new to the tracker, no prior reading

Visit Read the brief →

FDA warning letter, June 2026 — issued to FITISH. See the FDA's warning letter database.

No. 45 · Grade B−

Elara Health and Wellness

81/100

Elara bundles labs and coaching with treatment, but its lowest rates require fifty-two-week prepayment and all plans use four-week periods.

Semaglutide: $249 / 4 weeks injection
52 weeks: $2,327 upfront ($179 / 4 weeks equivalent); oral: $279 / 4 weeks.
Full price details
$249 every 4 weeks without prepayment; $2,327 upfront for 52 weeks ($179 per 4 weeks equivalent); oral $279 every 4 weeks
Coverage: Availability depends on state, clinical eligibility and assigned provider
Price trend: new to the tracker, no prior reading

Visit Read the brief →

No. 11 · Grade B+

REMEVi

87/100

English- and Spanish-language GLP-1 care with four-week billing, published prepaid totals and no advertised dose upcharge.

Semaglutide: $199 / 4 weeks
24-week option: $954 upfront ($159 per four weeks).
Full price details
$199 every 4 weeks; $954 prepaid for 24 weeks ($159 per 4 weeks)
Coverage: 49 states and DC; excludes Louisiana
Price trend: new to the tracker, no prior reading

Visit Read the brief →

No. 26 · Grade B

BetterMe Rx

85/100

BetterMe Rx includes dose adjustments and publishes its pharmacy network, but the selected plan needs a current renewal quote and clear cancellation terms.

Semaglutide: Confirm current price
Earlier listing: $199/mo (original check date not recorded).
Confirm the medication, billing term and full charge before paying.
Full price details
Compounded semaglutide offered. Current medication quote unknown; earlier listing: $199/mo
Coverage: All 50 states
Price trend: price stable

Visit Read the brief →

No. 150 · Grade C

NEUVÉ Health

71/100

Neuvé MD separates standard and microdose GLP-1 tiers, with 28-day treatment pricing, required laboratory charges and optional platform memberships.

Semaglutide: $217 per 28 days + labs
Standard compounded injection with B12; required testing costs extra. Separate microdose tier: $179 per 28 days.
Full price details
$217 every 28 days for the standard compounded semaglutide injection with B12; required labs extra; $179 microdose tier is separate
Coverage: Advertises all 50 states; service, clinical eligibility and pharmacy availability vary by location
Price trend: new to the tracker, no prior reading

Visit Read the brief →

No. 56 · Grade C

HealthSource

79/100

HealthSource includes medication and messaging, but four-week billing and conflicting refund deadlines deserve a closer look.

Semaglutide: From $199 / 4 weeks
Initial supply options vary; confirm the first quantity and later prescribed price.
Full price details
From $199 every 4 weeks (compounded injection; initial supply options vary)
Coverage: All 50 states
Price trend: new to the tracker, no prior reading

Visit Read the brief →

Read our full Goldspan Health brief →All comparisons →

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.